相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
Marcus Noel et al.
INVESTIGATIONAL NEW DRUGS (2020)
Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
Dongbo Li et al.
CANCER SCIENCE (2020)
CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis
Hui Yang et al.
MOLECULAR CANCER (2020)
Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
Bao-Hua Li et al.
MOLECULAR IMMUNOLOGY (2020)
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny et al.
NATURE MEDICINE (2020)
CXCR4, but not CXCR3, drives CD8+ T-cell entry into and migration through the murine bone marrow
Marieke Goedhart et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
Yongwoo David Seo et al.
CLINICAL CANCER RESEARCH (2019)
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow et al.
IMMUNITY (2019)
Chemokines and other mediators in the development and functional organization of lymph nodes
Nadine Eckert et al.
IMMUNOLOGICAL REVIEWS (2019)
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Andrea Walens et al.
ELIFE (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Xuanmao Jiao et al.
CANCER RESEARCH (2019)
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer
Shingo Maeda et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X
Emily Levy et al.
FRONTIERS IN IMMUNOLOGY (2019)
Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment
Juhee Jeong et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Maria Teresa Masucci et al.
FRONTIERS IN ONCOLOGY (2019)
Cyclooxygenase-2 in cancer: A review
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer
Marja Heiskala et al.
VIRCHOWS ARCHIV (2019)
Dendritic cell subsets in T cell programming: location dictates function
S. C. Eisenbarth
NATURE REVIEWS IMMUNOLOGY (2019)
CCL3 augments tumor rejection and enhances CD8(+) T cell infiltration through NK and CD103(+) dendritic cell recruitment via IFN
Frederick Allen et al.
ONCOIMMUNOLOGY (2018)
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
Pranabananda Dutta et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
David Linehan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CXCR4 antagonist (BL-8040) to enhance antitumor effects by increasing tumor infiltration of antigen-specific effector T-cells.
Pankaj Gaur et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
Santosh Kumar Singh et al.
SCIENTIFIC REPORTS (2018)
The Expanding Therapeutic Perspective of CCR5 Blockade
Luca Vangelista et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-alpha and MMP-9
Seungeun Lee et al.
CANCER LETTERS (2018)
CXCR3-deficient natural killer cells fail to migrate to B16F10 melanoma cells
Juyoung Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo
Davalyn Powell et al.
SCIENTIFIC REPORTS (2018)
The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment
Katharina Helene Susek et al.
FRONTIERS IN IMMUNOLOGY (2018)
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Maria Georganaki et al.
FRONTIERS IN IMMUNOLOGY (2018)
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
Iva Truxova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
CCR5(+) Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions
Carolin Blattner et al.
CANCER RESEARCH (2018)
Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication
Samantha Burugu et al.
BREAST CANCER (2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Torsten Hartwig et al.
MOLECULAR CELL (2017)
Regulatory T Cells: Central Concepts from Ontogeny to Therapy
Bernard Khor
TRANSFUSION MEDICINE REVIEWS (2017)
Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists
Nicholas Kindon et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
CCR5 Directs the Mobilization of CD11b+Gr1+Ly6Clow Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Developmen
Elias Hawila et al.
CELL REPORTS (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments
Teizo Yoshimura
CYTOKINE (2017)
Dendritic cell migration in health and disease
Tim Worbs et al.
NATURE REVIEWS IMMUNOLOGY (2017)
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Tristan A. Barnes et al.
BRITISH JOURNAL OF CANCER (2017)
Monocyte differentiation and antigen-presenting functions
Claudia V. Jakubzick et al.
NATURE REVIEWS IMMUNOLOGY (2017)
CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
Zuqiang Liu et al.
ONCOIMMUNOLOGY (2016)
Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
Yongkui Li et al.
ONCOIMMUNOLOGY (2016)
Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics
Olga Schulz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
Holger Bronger et al.
BRITISH JOURNAL OF CANCER (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases
Ileana S. Mauldin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors
Zinal S. Chheda et al.
JOURNAL OF IMMUNOLOGY (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis
Craig M. Brackett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Neutrophils in the Tumor Microenvironment
Davalyn R. Powell et al.
TRENDS IN IMMUNOLOGY (2016)
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Su Yin Lim et al.
ONCOTARGET (2016)
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
Timothy Chao et al.
CANCER IMMUNOLOGY RESEARCH (2016)
CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
Ryuichiro Arakaki et al.
CANCER MEDICINE (2016)
CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice
Xuguang Chen et al.
PLOS ONE (2016)
The role of myeloid cells in cancer therapies
Camilla Engblom et al.
NATURE REVIEWS CANCER (2016)
Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages
Casey Frankenberger et al.
CANCER RESEARCH (2015)
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
Koji Kurose et al.
CLINICAL CANCER RESEARCH (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma
Andrea Ladanyi
PIGMENT CELL & MELANOMA RESEARCH (2015)
Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2
Malika Hale et al.
PLOS ONE (2015)
The Chemokine System in Innate Immunity
Caroline L. Sokol et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
M. E. Mikucki et al.
NATURE COMMUNICATIONS (2015)
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling
Laura Brandolini et al.
ONCOTARGET (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome
Xiao Ni et al.
CLINICAL CANCER RESEARCH (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
Jeremy Goc et al.
CANCER RESEARCH (2014)
Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
Ruey-Shyang Soong et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β
J. Jablonska et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Multicenter Phase II Study of Mogamulizumab ( KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Michinori Ogura et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cutting Edge: CXCR4 Is Critical for CD8+ Memory T Cell Homeostatic Self-Renewal but Not Rechallenge Self-Renewal
Julie Chaix et al.
JOURNAL OF IMMUNOLOGY (2014)
A novel recombinant protein of IP10-EGFRvIIIscFv and CD8+ cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice
Xuan Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Immune cells: plastic players along colorectal cancer progression
Giuseppe Di Caro et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression
M. A. Lopez-Lago et al.
ONCOGENE (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
Anthony Cahn et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines
Weiyi Peng et al.
CANCER RESEARCH (2012)
Tumor-associated neutrophils: friend or foe?
Zvi G. Fridlender et al.
CARCINOGENESIS (2012)
CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα
Guangwen Ren et al.
CELL STEM CELL (2012)
Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma
Shao-Lai Zhou et al.
HEPATOLOGY (2012)
The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
Yan Ning et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer
Holger Bronger et al.
BREAST CANCER RESEARCH (2012)
CXCL12-CXCR4 chemokine signaling is essential for NK-cell development in adult mice
Mamiko Noda et al.
BLOOD (2011)
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens
Helene Pere et al.
BLOOD (2011)
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
Michelle L. Varney et al.
CANCER LETTERS (2011)
Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells
Julien Faget et al.
CANCER RESEARCH (2011)
Role of CXCR3 Ligands in IL-7/IL-7Rα-Fc-Mediated Antitumor Activity in Lung Cancer
Asa Andersson et al.
CLINICAL CANCER RESEARCH (2011)
Targeting the CXCR4-CXCL12 Axis Mobilizes Autologous Hematopoietic Stem Cells and Prolongs Islet Allograft Survival via Programmed Death Ligand 1
Paolo Fiorina et al.
JOURNAL OF IMMUNOLOGY (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
Bernhard Mlecnik et al.
GASTROENTEROLOGY (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Michael Gobert et al.
CANCER RESEARCH (2009)
Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis
Seema Singh et al.
CLINICAL CANCER RESEARCH (2009)
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Kosuke Mizutani et al.
NEOPLASIA (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Chemokines and their receptors: Drug targets in immunity and inflammation
Antonella Viola et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
Yoshiki Mizukami et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
CCR7 and its ligands:: balancing immunity and tolerance
Reinhold Foerster et al.
NATURE REVIEWS IMMUNOLOGY (2008)
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Bo Huang et al.
CANCER LETTERS (2007)
CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration
Robert D. Loberg et al.
NEOPLASIA (2007)
Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy
Karen L. Reckamp et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder
Sami Tsukishiro et al.
GYNECOLOGIC ONCOLOGY (2006)
Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma
R. Zhang et al.
GENE THERAPY (2006)
Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege
Takashi Ishida et al.
CANCER RESEARCH (2006)
Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control
Fabrizio Vianello et al.
JOURNAL OF IMMUNOLOGY (2006)
CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis
JD Pan et al.
JOURNAL OF IMMUNOLOGY (2006)
Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth
YS Sun et al.
CANCER GENE THERAPY (2005)
The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis
PJ Hensbergen et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Induction of potent antitumor immunity by in situ targeting of intraturnoral DCs
K Furumoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease
IM Mullins et al.
CANCER RESEARCH (2004)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts
AL Feldman et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Elevated expression of CCR5 by myeloid (CD11c(+)) blood dendritic cells in multiple sclerosis and acute optic neuritis
M Pashenkov et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Interleukin-8 and human cancer biology
KP Xie
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
Improved survival in tumor-bearing SCID mice treated with interferon-γ-inducible protein 10 (IP-10/CXCL10)
DA Arenberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle
E Van Coillie et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines
C Caux et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2000)
CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells
J Aliberti et al.
NATURE IMMUNOLOGY (2000)
分享论文
